While debate rages on about the efficacy of hydroxychloroquine, studies haven shown that countries […]
Geltor, a San Francisco-based bio-design tech startup that makes designer proteins for consumers, with […]
The Association of American Physicians and Surgeons (AAPS) is a non-partisan and non-profit professional association […]
For months, researchers and health officials have been preoccupied with therapeutic drugs like remdesivir and […]
This is a guest post by serial entrepreneur Keld van Schreven, Co-Founder and Managing […]
We have more good news on multiple fronts in the race to develop vaccine […]
We covered Paige back in April after the New York City-based artificial intelligence startup secured $5 […]
Another day, another remdesivir and hydroxychloroquine study. Even after a study published in the New […]
For over four months now, the naysayers have been warning us about the danger […]
We’ve been covering the story of Moderna vaccine development for a few months now. Moderna […]
Coronavirus cases are increasing in at least 37 states in the United States. Yesterday, […]
Last week, we told you about Dexamethasone after scientists in the U.K. found the […]
GreenLight Biosciences, a Medford, MA-based biotech startup focused on sustainable production of chemicals and fuels, […]
Back in March we told you about hydroxychloroquine after the Food and Drug Administration (FDA) issued […]
Last month, we told you about Moderna after the company announced positive results of […]
By 2024, the global pharmaceutical industry is expected to become a $1.18 trillion market […]
Earlier today, we wrote an article titled, “Social distancing versus social justice: After weeks […]
For over 5 months now, the Chinese government and other health officials have been […]
The last time we wrote about Bolt was back in March 2018 when the […]
On Monday, we told you about Moderna after the pharmaceutical giant announced that its […]